NovoCure Limited Profile Avatar - Palmy Investing

NovoCure Limited

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and G…

Medical - Instruments & Supplies
JE, Saint Helier [HQ]
NVCR/Leadership and Strategy

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of NVCR's Analysis
CIK: 1645113 CUSIP: G6674U108 ISIN: JE00BYSS4X48 LEI: - UEI: -
Secondary Listings
NVCR has no secondary listings inside our databases.